Open Data in Clinical Trials

In a recent New England Journal of Medicine editorial titled, “Open Data,” Jeffrey M. Drazen, MD, describes an Institute of Medicine (IOM) committee examining the sharing of data in clinical trials. The committee is charged with “reviewing current practices on data sharing in the context of randomized, controlled trials and with making recommendations for future data-sharing standards.”1   A draft report of the committee’s work can be found at

The committee is collecting comments on their draft report as well as comments about the sharing of clinical trial data. Comments will be collected until March 24, 2014, at

1. J.M. Drazen, “Open Data,” New England Journal of Medicine, January 22, 2014,

~ Nancy Tannery